1.
Full Text
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Nature, ISSN 0028-0836, 11/2014, Volume 515, Issue 7527, pp. 431 - 435
Ischaemia-reperfusion injury occurs when the blood supply to an organ is disrupted and then restored, and underlies many disorders, notably heart attack and...
STROKE | HYPOXIA-ISCHEMIA | MECHANISM | COMPLEX-I | SUPEROXIDE-PRODUCTION | MULTIDISCIPLINARY SCIENCES | PURINE NUCLEOTIDE CYCLE | CONSEQUENCES | CARDIOPROTECTION | HYPERTENSIVE-RATS | DEHYDROGENASE | Metabolomics | Mitochondria - enzymology | Electron Transport | Reactive Oxygen Species - metabolism | Ischemia - enzymology | Male | Electron Transport Complex I - metabolism | Myocytes, Cardiac - enzymology | Myocardium - metabolism | Malates - metabolism | Reperfusion Injury - metabolism | NAD - metabolism | Disease Models, Animal | Myocardial Infarction - enzymology | Adenosine Monophosphate - metabolism | Reperfusion Injury - enzymology | Ischemia - metabolism | Mitochondria - metabolism | Myocardial Infarction - metabolism | Citric Acid Cycle | Myocardium - cytology | Stroke - enzymology | Myocardium - enzymology | Stroke - metabolism | Animals | Succinic Acid - metabolism | Fumarates - metabolism | Myocytes, Cardiac - metabolism | Aspartic Acid - metabolism | Succinate Dehydrogenase - metabolism | Mice | Reactive oxygen species | Research | Succinates | Health aspects | Analysis | Reperfusion injury | Heart | Stroke | Glucose | Metabolites | Metabolism | Carbon
STROKE | HYPOXIA-ISCHEMIA | MECHANISM | COMPLEX-I | SUPEROXIDE-PRODUCTION | MULTIDISCIPLINARY SCIENCES | PURINE NUCLEOTIDE CYCLE | CONSEQUENCES | CARDIOPROTECTION | HYPERTENSIVE-RATS | DEHYDROGENASE | Metabolomics | Mitochondria - enzymology | Electron Transport | Reactive Oxygen Species - metabolism | Ischemia - enzymology | Male | Electron Transport Complex I - metabolism | Myocytes, Cardiac - enzymology | Myocardium - metabolism | Malates - metabolism | Reperfusion Injury - metabolism | NAD - metabolism | Disease Models, Animal | Myocardial Infarction - enzymology | Adenosine Monophosphate - metabolism | Reperfusion Injury - enzymology | Ischemia - metabolism | Mitochondria - metabolism | Myocardial Infarction - metabolism | Citric Acid Cycle | Myocardium - cytology | Stroke - enzymology | Myocardium - enzymology | Stroke - metabolism | Animals | Succinic Acid - metabolism | Fumarates - metabolism | Myocytes, Cardiac - metabolism | Aspartic Acid - metabolism | Succinate Dehydrogenase - metabolism | Mice | Reactive oxygen species | Research | Succinates | Health aspects | Analysis | Reperfusion injury | Heart | Stroke | Glucose | Metabolites | Metabolism | Carbon
Journal Article
Antioxidants & Redox Signaling, ISSN 1523-0864, 10/2011, Volume 15, Issue 7, pp. 1835 - 1846
The intrinsic defense mechanisms of the body are critical in protecting tissues from injury in response to pathological stress. Heme oxygenase-1 (HO-1), a...
Forum Review Articles | GRAFT ARTERIOSCLEROSIS | ENDOTHELIAL PROGENITOR CELLS | MATRIX METALLOPROTEINASES | CARBON-MONOXIDE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOCRINOLOGY & METABOLISM | ACUTE MYOCARDIAL-INFARCTION | ATHEROSCLEROTIC LESION FORMATION | SMOOTH-MUSCLE-CELLS | CORONARY-ARTERY-DISEASE | SIROLIMUS-ELUTING STENTS | MICROSATELLITE POLYMORPHISM | Genetic Therapy | Heme Oxygenase-1 - metabolism | Diabetes Complications | Humans | Arteries - injuries | Heme Oxygenase-1 - genetics | Neovascularization, Pathologic - enzymology | Atherosclerosis - enzymology | Plaque, Atherosclerotic - enzymology | Plaque, Atherosclerotic - pathology | Graft Rejection - pathology | Microsatellite Repeats | Graft Rejection - enzymology | Atherosclerosis - pathology | Coronary Vessels - pathology | Coronary Vessels - enzymology | Thrombosis - enzymology | Myocardium - pathology | Graft Occlusion, Vascular - enzymology | Heart Diseases - enzymology | Thrombosis - pathology | Heart Diseases - etiology | Myocardium - enzymology | Animals | Arteries - enzymology | Graft Occlusion, Vascular - pathology | Heart Diseases - therapy | Hypoxia | Heart Diseases - pathology | Oxidases | Physiological aspects | Care and treatment | Research | Cardiovascular diseases
Forum Review Articles | GRAFT ARTERIOSCLEROSIS | ENDOTHELIAL PROGENITOR CELLS | MATRIX METALLOPROTEINASES | CARBON-MONOXIDE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOCRINOLOGY & METABOLISM | ACUTE MYOCARDIAL-INFARCTION | ATHEROSCLEROTIC LESION FORMATION | SMOOTH-MUSCLE-CELLS | CORONARY-ARTERY-DISEASE | SIROLIMUS-ELUTING STENTS | MICROSATELLITE POLYMORPHISM | Genetic Therapy | Heme Oxygenase-1 - metabolism | Diabetes Complications | Humans | Arteries - injuries | Heme Oxygenase-1 - genetics | Neovascularization, Pathologic - enzymology | Atherosclerosis - enzymology | Plaque, Atherosclerotic - enzymology | Plaque, Atherosclerotic - pathology | Graft Rejection - pathology | Microsatellite Repeats | Graft Rejection - enzymology | Atherosclerosis - pathology | Coronary Vessels - pathology | Coronary Vessels - enzymology | Thrombosis - enzymology | Myocardium - pathology | Graft Occlusion, Vascular - enzymology | Heart Diseases - enzymology | Thrombosis - pathology | Heart Diseases - etiology | Myocardium - enzymology | Animals | Arteries - enzymology | Graft Occlusion, Vascular - pathology | Heart Diseases - therapy | Hypoxia | Heart Diseases - pathology | Oxidases | Physiological aspects | Care and treatment | Research | Cardiovascular diseases
Journal Article
Biochemical Journal, ISSN 0264-6021, 08/2004, Volume 381, Issue 3, pp. 761 - 767
An important regulator involved in oxygen-dependent gene expression is the transcription factor HIF (hypoxia-inducible factor), which is composed of an...
Post-translational modification | Hypoxia-inducible factor | Protein degradation | Oxygen sensing | Prolyl hydroxylation | Von-Hippel-Lindau protein | TRANSCRIPTIONAL ACTIVITY | PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | ALPHA | hypoxia-inducible factor | oxygen sensing | post-translational modification | von-Hippel-Lindau protein | FAMILY | OXYGEN | FACTOR-1-ALPHA | GENE-EXPRESSION | HIF-1-ALPHA | VHL | protein degradation | prolyl hydroxylation | Humans | Half-Life | Kidney Neoplasms - metabolism | Ubiquitin-Protein Ligases - physiology | Bone Neoplasms - pathology | Hypoxia-Inducible Factor 1, alpha Subunit | RNA, Messenger - biosynthesis | Liver Neoplasms - pathology | Liver Neoplasms - enzymology | Kidney Tubules, Proximal - cytology | DNA-Binding Proteins - physiology | Hypoxia - enzymology | Hydroxylation | Hypoxia-Inducible Factor 1 | Immediate-Early Proteins - biosynthesis | Carcinoma, Hepatocellular - enzymology | Tumor Suppressor Proteins - physiology | Epithelial Cells - enzymology | Liver Neoplasms - metabolism | Cell Line, Tumor | Von Hippel-Lindau Tumor Suppressor Protein | Enzyme Induction - physiology | Osteosarcoma - pathology | Carcinoma, Hepatocellular - metabolism | Epithelial Cells - metabolism | Gene Expression Regulation, Enzymologic - physiology | Oxygen - metabolism | Procollagen-Proline Dioxygenase - biosynthesis | Bone Neoplasms - metabolism | Procollagen-Proline Dioxygenase - metabolism | DNA-Binding Proteins - metabolism | Kidney Tubules, Proximal - enzymology | Gene Expression Regulation, Neoplastic - physiology | Osteosarcoma - metabolism | Cell Line | Transcription Factors - physiology | Bone Neoplasms - enzymology | Osteosarcoma - enzymology | Adenocarcinoma, Clear Cell - metabolism | Nuclear Proteins - metabolism | Hypoxia-Inducible Factor-Proline Dioxygenases | Dioxygenases | Transcription Factors - metabolism | Kidney Neoplasms - enzymology | Carcinoma, Hepatocellular - pathology | Kidney Tubules, Proximal - metabolism | Kidney Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Nuclear Proteins - physiology | Adenocarcinoma, Clear Cell - enzymology | DNA-Binding Proteins - biosynthesis | ODD, oxygen-dependent degradation domain | aRP, acidic ribosomal protein | RNAi, RNA interference | pVHL, von-Hippel-Lindau protein | EGLN, egg-laying deficient nine-like protein | HIF, hypoxia-inducible factor | siRNA, small interfering RNA | IVTT, in vitro transcription | PHD, prolyl hydroxylase domain containing protein | translation | RT, reverse transcriptase | RPTEC, human renal proximal tubular epithelial cells
Post-translational modification | Hypoxia-inducible factor | Protein degradation | Oxygen sensing | Prolyl hydroxylation | Von-Hippel-Lindau protein | TRANSCRIPTIONAL ACTIVITY | PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | ALPHA | hypoxia-inducible factor | oxygen sensing | post-translational modification | von-Hippel-Lindau protein | FAMILY | OXYGEN | FACTOR-1-ALPHA | GENE-EXPRESSION | HIF-1-ALPHA | VHL | protein degradation | prolyl hydroxylation | Humans | Half-Life | Kidney Neoplasms - metabolism | Ubiquitin-Protein Ligases - physiology | Bone Neoplasms - pathology | Hypoxia-Inducible Factor 1, alpha Subunit | RNA, Messenger - biosynthesis | Liver Neoplasms - pathology | Liver Neoplasms - enzymology | Kidney Tubules, Proximal - cytology | DNA-Binding Proteins - physiology | Hypoxia - enzymology | Hydroxylation | Hypoxia-Inducible Factor 1 | Immediate-Early Proteins - biosynthesis | Carcinoma, Hepatocellular - enzymology | Tumor Suppressor Proteins - physiology | Epithelial Cells - enzymology | Liver Neoplasms - metabolism | Cell Line, Tumor | Von Hippel-Lindau Tumor Suppressor Protein | Enzyme Induction - physiology | Osteosarcoma - pathology | Carcinoma, Hepatocellular - metabolism | Epithelial Cells - metabolism | Gene Expression Regulation, Enzymologic - physiology | Oxygen - metabolism | Procollagen-Proline Dioxygenase - biosynthesis | Bone Neoplasms - metabolism | Procollagen-Proline Dioxygenase - metabolism | DNA-Binding Proteins - metabolism | Kidney Tubules, Proximal - enzymology | Gene Expression Regulation, Neoplastic - physiology | Osteosarcoma - metabolism | Cell Line | Transcription Factors - physiology | Bone Neoplasms - enzymology | Osteosarcoma - enzymology | Adenocarcinoma, Clear Cell - metabolism | Nuclear Proteins - metabolism | Hypoxia-Inducible Factor-Proline Dioxygenases | Dioxygenases | Transcription Factors - metabolism | Kidney Neoplasms - enzymology | Carcinoma, Hepatocellular - pathology | Kidney Tubules, Proximal - metabolism | Kidney Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Nuclear Proteins - physiology | Adenocarcinoma, Clear Cell - enzymology | DNA-Binding Proteins - biosynthesis | ODD, oxygen-dependent degradation domain | aRP, acidic ribosomal protein | RNAi, RNA interference | pVHL, von-Hippel-Lindau protein | EGLN, egg-laying deficient nine-like protein | HIF, hypoxia-inducible factor | siRNA, small interfering RNA | IVTT, in vitro transcription | PHD, prolyl hydroxylase domain containing protein | translation | RT, reverse transcriptase | RPTEC, human renal proximal tubular epithelial cells
Journal Article
Circulation Research, ISSN 0009-7330, 08/2007, Volume 101, Issue 3, pp. 258 - 267
Nonphagocytic NADPH oxidases have recently been suggested to play a major role in the regulation of physiological and pathophysiological processes, in...
Vascular smooth muscle cell proliferation | Hypoxia | Hypoxic pulmonary vasoconstriction | NADPH oxidase | Pulmonary hypertension | hypoxia | CARDIAC & CARDIOVASCULAR SYSTEMS | TGF-BETA | hypoxic pulmonary vasoconstriction | SUPEROXIDE-PRODUCTION | pulmonary hypertension | PROLIFERATION | vascular smooth muscle cell proliferation | NAD(P)H OXIDASE | ENDOTHELIAL-CELLS | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | CARDIOVASCULAR-DISEASES | ARTERY | HEMATOLOGY | VASOCONSTRICTION | Membrane Glycoproteins - analysis | Oxygen - pharmacology | Protein Subunits | Tunica Media - pathology | Humans | Myocytes, Smooth Muscle - pathology | Hypertension, Pulmonary - physiopathology | Male | Oxygen - metabolism | RNA, Messenger - biosynthesis | RNA Interference | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Cell Division | Drug Design | Superoxides - metabolism | NADPH Oxidases - genetics | Female | Hypertension, Pulmonary - drug therapy | NADPH Oxidases - biosynthesis | Hypertension, Pulmonary - enzymology | Endoplasmic Reticulum - enzymology | Cells, Cultured - drug effects | Hypoxia - enzymology | Myocytes, Smooth Muscle - enzymology | NADPH Oxidases - analysis | RNA, Small Interfering - pharmacology | Enzyme Induction | Nitric Oxide - physiology | Hypoxia - complications | NADPH Oxidase 4 | Organ Specificity | NADPH Oxidase 2 | Transforming Growth Factor beta1 - physiology | Cells, Cultured - enzymology | Pulmonary Artery - enzymology | Pulmonary Artery - cytology | Animals | Hypoxia - physiopathology | Lung - blood supply | Chronic Disease | Hypertension, Pulmonary - etiology | NADPH Oxidases - physiology | Tunica Media - enzymology | Hypertrophy
Vascular smooth muscle cell proliferation | Hypoxia | Hypoxic pulmonary vasoconstriction | NADPH oxidase | Pulmonary hypertension | hypoxia | CARDIAC & CARDIOVASCULAR SYSTEMS | TGF-BETA | hypoxic pulmonary vasoconstriction | SUPEROXIDE-PRODUCTION | pulmonary hypertension | PROLIFERATION | vascular smooth muscle cell proliferation | NAD(P)H OXIDASE | ENDOTHELIAL-CELLS | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | CARDIOVASCULAR-DISEASES | ARTERY | HEMATOLOGY | VASOCONSTRICTION | Membrane Glycoproteins - analysis | Oxygen - pharmacology | Protein Subunits | Tunica Media - pathology | Humans | Myocytes, Smooth Muscle - pathology | Hypertension, Pulmonary - physiopathology | Male | Oxygen - metabolism | RNA, Messenger - biosynthesis | RNA Interference | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Cell Division | Drug Design | Superoxides - metabolism | NADPH Oxidases - genetics | Female | Hypertension, Pulmonary - drug therapy | NADPH Oxidases - biosynthesis | Hypertension, Pulmonary - enzymology | Endoplasmic Reticulum - enzymology | Cells, Cultured - drug effects | Hypoxia - enzymology | Myocytes, Smooth Muscle - enzymology | NADPH Oxidases - analysis | RNA, Small Interfering - pharmacology | Enzyme Induction | Nitric Oxide - physiology | Hypoxia - complications | NADPH Oxidase 4 | Organ Specificity | NADPH Oxidase 2 | Transforming Growth Factor beta1 - physiology | Cells, Cultured - enzymology | Pulmonary Artery - enzymology | Pulmonary Artery - cytology | Animals | Hypoxia - physiopathology | Lung - blood supply | Chronic Disease | Hypertension, Pulmonary - etiology | NADPH Oxidases - physiology | Tunica Media - enzymology | Hypertrophy
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 11/2009, Volume 29, Issue 21, pp. 5729 - 5741
Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
INACTIVATION | HEART | TRANSCRIPTIONAL ACTIVITY | MYOCARDIAL-INFARCTION | HIF | BIOCHEMISTRY & MOLECULAR BIOLOGY | MITOCHONDRIAL AUTOPHAGY | MOUSE MODEL | VASCULAR TUMORS | INDUCIBLE-FACTOR | PAS DOMAIN PROTEIN | CELL BIOLOGY | Mitochondria - enzymology | Liver - pathology | Liver - enzymology | Kidney - pathology | Kidney - enzymology | Polycythemia - complications | Cardiomyopathies - enzymology | Procollagen-Proline Dioxygenase - metabolism | Cell Hypoxia | Cardiomyopathies - physiopathology | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Heart Function Tests | Von Hippel-Lindau Tumor Suppressor Protein - metabolism | Myocardium - ultrastructure | Mammals - metabolism | Cardiomegaly - physiopathology | Hypoxia-Inducible Factor-Proline Dioxygenases | Cardiomegaly - enzymology | Mitochondria - pathology | Cardiomegaly - complications | Feedback, Physiological | Myocardium - enzymology | Animals | Polycythemia - enzymology | Procollagen-Proline Dioxygenase - deficiency | Survival Analysis | Cardiomyopathies - complications | Mice | Polycythemia - physiopathology | Enzyme Activation
INACTIVATION | HEART | TRANSCRIPTIONAL ACTIVITY | MYOCARDIAL-INFARCTION | HIF | BIOCHEMISTRY & MOLECULAR BIOLOGY | MITOCHONDRIAL AUTOPHAGY | MOUSE MODEL | VASCULAR TUMORS | INDUCIBLE-FACTOR | PAS DOMAIN PROTEIN | CELL BIOLOGY | Mitochondria - enzymology | Liver - pathology | Liver - enzymology | Kidney - pathology | Kidney - enzymology | Polycythemia - complications | Cardiomyopathies - enzymology | Procollagen-Proline Dioxygenase - metabolism | Cell Hypoxia | Cardiomyopathies - physiopathology | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Heart Function Tests | Von Hippel-Lindau Tumor Suppressor Protein - metabolism | Myocardium - ultrastructure | Mammals - metabolism | Cardiomegaly - physiopathology | Hypoxia-Inducible Factor-Proline Dioxygenases | Cardiomegaly - enzymology | Mitochondria - pathology | Cardiomegaly - complications | Feedback, Physiological | Myocardium - enzymology | Animals | Polycythemia - enzymology | Procollagen-Proline Dioxygenase - deficiency | Survival Analysis | Cardiomyopathies - complications | Mice | Polycythemia - physiopathology | Enzyme Activation
Journal Article
CELL DEATH & DISEASE, ISSN 2041-4889, 02/2018, Volume 9, Issue 2, pp. 221 - 10
Calcification is a major risk factor for vascular integrity. This pathological symptom and the underlying mechanisms in hypoxic pulmonary artery hypertension...
APOPTOSIS | STIM1 | CHAPERONE-MEDIATED AUTOPHAGY | INFLAMMATION | ARTERIAL-HYPERTENSION | DISEASE | DEGRADATION | MECHANISMS | 15-LIPOXYGENASE | EXPRESSION | CELL BIOLOGY | Calcinosis - genetics | Rats, Wistar | Myocytes, Smooth Muscle - pathology | Apoptosis - genetics | Male | Killer Cells, Natural - pathology | Granzymes - genetics | Calcinosis - chemically induced | Hypertension, Pulmonary - chemically induced | T-Lymphocytes, Cytotoxic - pathology | Cell Differentiation | Hypertension, Pulmonary - enzymology | Monocrotaline - administration & dosage | Hypoxia - enzymology | Calcium Channels | Osteoblasts - enzymology | Signal Transduction | Myocytes, Smooth Muscle - enzymology | Mice, Inbred C57BL | Gene Expression Regulation | Hypertension, Pulmonary - genetics | Mice, Transgenic | Calcinosis - enzymology | Rats, Sprague-Dawley | T-Lymphocytes, Cytotoxic - enzymology | Pulmonary Artery - enzymology | Killer Cells, Natural - enzymology | Granzymes - deficiency | Osteoblasts - pathology | Hypoxia - genetics | Muscle, Smooth, Vascular - pathology | Animals | Hypoxia - pathology | Mice | Hypoxia - chemically induced | Primary Cell Culture | Calcinosis - pathology | Hypertension, Pulmonary - pathology | Muscle, Smooth, Vascular - enzymology | Pulmonary Artery - pathology | Hypertension | Calcification (ectopic) | Phenotypes | Calcium channels | Animal models | Pulmonary arteries | Cytotoxicity | Smooth muscle | Lymphocytes T | Osteoblasts | Pulmonary artery | Granzyme B | Osteoblastogenesis | Mineralization | Arteriosclerosis | Calcification | Hypoxia | Natural killer cells | Apoptosis
APOPTOSIS | STIM1 | CHAPERONE-MEDIATED AUTOPHAGY | INFLAMMATION | ARTERIAL-HYPERTENSION | DISEASE | DEGRADATION | MECHANISMS | 15-LIPOXYGENASE | EXPRESSION | CELL BIOLOGY | Calcinosis - genetics | Rats, Wistar | Myocytes, Smooth Muscle - pathology | Apoptosis - genetics | Male | Killer Cells, Natural - pathology | Granzymes - genetics | Calcinosis - chemically induced | Hypertension, Pulmonary - chemically induced | T-Lymphocytes, Cytotoxic - pathology | Cell Differentiation | Hypertension, Pulmonary - enzymology | Monocrotaline - administration & dosage | Hypoxia - enzymology | Calcium Channels | Osteoblasts - enzymology | Signal Transduction | Myocytes, Smooth Muscle - enzymology | Mice, Inbred C57BL | Gene Expression Regulation | Hypertension, Pulmonary - genetics | Mice, Transgenic | Calcinosis - enzymology | Rats, Sprague-Dawley | T-Lymphocytes, Cytotoxic - enzymology | Pulmonary Artery - enzymology | Killer Cells, Natural - enzymology | Granzymes - deficiency | Osteoblasts - pathology | Hypoxia - genetics | Muscle, Smooth, Vascular - pathology | Animals | Hypoxia - pathology | Mice | Hypoxia - chemically induced | Primary Cell Culture | Calcinosis - pathology | Hypertension, Pulmonary - pathology | Muscle, Smooth, Vascular - enzymology | Pulmonary Artery - pathology | Hypertension | Calcification (ectopic) | Phenotypes | Calcium channels | Animal models | Pulmonary arteries | Cytotoxicity | Smooth muscle | Lymphocytes T | Osteoblasts | Pulmonary artery | Granzyme B | Osteoblastogenesis | Mineralization | Arteriosclerosis | Calcification | Hypoxia | Natural killer cells | Apoptosis
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2014, Volume 34, Issue 7, pp. 1446 - 1458
OBJECTIVE—Pulmonary vascular remodeling, the pathological hallmark of pulmonary arterial hypertension, is attributed to proliferation, apoptosis resistance,...
anoxia | muscle | pulmonary | protein-lysine 6-oxidase | hypertension | extracellular matrix | smooth | COLLAGEN | muscle, smooth | AORTIC-ANEURYSMS | RAT | BONE MORPHOGENETIC PROTEIN | hypertension, pulmonary | PROLIFERATION | HYPOXIA | CROSS-TALK | GROWTH-FACTORS | ELASTIN | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | HEMATOLOGY | Antihypertensive Agents - pharmacology | Fibroblasts - enzymology | Humans | Middle Aged | Monocrotaline | Myocytes, Smooth Muscle - pathology | Male | Hypertrophy, Right Ventricular - etiology | RNA, Messenger - metabolism | Ventricular Dysfunction, Right - enzymology | Case-Control Studies | Cell Hypoxia | Young Adult | Aged, 80 and over | Adult | Female | Ventricular Dysfunction, Right - physiopathology | Hypertension, Pulmonary - drug therapy | Hypertension, Pulmonary - enzymology | Disease Models, Animal | Elastin - metabolism | Isoenzymes | Myocytes, Smooth Muscle - enzymology | Cells, Cultured | Enzyme Inhibitors - pharmacology | Rats | Familial Primary Pulmonary Hypertension | Hypertension, Pulmonary - genetics | Hypoxia - complications | Pulmonary Artery - drug effects | Fibroblasts - pathology | Hypertrophy, Right Ventricular - enzymology | Pulmonary Artery - enzymology | Gene Expression Regulation, Enzymologic | Ventricular Dysfunction, Right - prevention & control | Collagen - metabolism | Protein-Lysine 6-Oxidase - antagonists & inhibitors | Muscle, Smooth, Vascular - pathology | Animals | Ventricular Dysfunction, Right - etiology | Protein-Lysine 6-Oxidase - metabolism | Hypertrophy, Right Ventricular - prevention & control | Mice | Protein-Lysine 6-Oxidase - genetics | Hypertension, Pulmonary - etiology | Hypertension, Pulmonary - pathology | Muscle, Smooth, Vascular - enzymology | Pulmonary Artery - pathology
anoxia | muscle | pulmonary | protein-lysine 6-oxidase | hypertension | extracellular matrix | smooth | COLLAGEN | muscle, smooth | AORTIC-ANEURYSMS | RAT | BONE MORPHOGENETIC PROTEIN | hypertension, pulmonary | PROLIFERATION | HYPOXIA | CROSS-TALK | GROWTH-FACTORS | ELASTIN | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | HEMATOLOGY | Antihypertensive Agents - pharmacology | Fibroblasts - enzymology | Humans | Middle Aged | Monocrotaline | Myocytes, Smooth Muscle - pathology | Male | Hypertrophy, Right Ventricular - etiology | RNA, Messenger - metabolism | Ventricular Dysfunction, Right - enzymology | Case-Control Studies | Cell Hypoxia | Young Adult | Aged, 80 and over | Adult | Female | Ventricular Dysfunction, Right - physiopathology | Hypertension, Pulmonary - drug therapy | Hypertension, Pulmonary - enzymology | Disease Models, Animal | Elastin - metabolism | Isoenzymes | Myocytes, Smooth Muscle - enzymology | Cells, Cultured | Enzyme Inhibitors - pharmacology | Rats | Familial Primary Pulmonary Hypertension | Hypertension, Pulmonary - genetics | Hypoxia - complications | Pulmonary Artery - drug effects | Fibroblasts - pathology | Hypertrophy, Right Ventricular - enzymology | Pulmonary Artery - enzymology | Gene Expression Regulation, Enzymologic | Ventricular Dysfunction, Right - prevention & control | Collagen - metabolism | Protein-Lysine 6-Oxidase - antagonists & inhibitors | Muscle, Smooth, Vascular - pathology | Animals | Ventricular Dysfunction, Right - etiology | Protein-Lysine 6-Oxidase - metabolism | Hypertrophy, Right Ventricular - prevention & control | Mice | Protein-Lysine 6-Oxidase - genetics | Hypertension, Pulmonary - etiology | Hypertension, Pulmonary - pathology | Muscle, Smooth, Vascular - enzymology | Pulmonary Artery - pathology
Journal Article
The Journal of Immunology, ISSN 0022-1767, 06/2007, Volume 178, Issue 11, pp. 7405 - 7411
Angiopoietins 1 and 2 bind to Tie-2 expressed on endothelial cells and regulate vessel stabilization and angiogenesis. Tie-2(+) monocytes have been shown to be...
TUMOR-NECROSIS-FACTOR | HUMAN PERIPHERAL-BLOOD | ANGIOGENESIS | MACROPHAGES | INFLAMMATION | ENDOTHELIAL-CELLS | IN-VIVO | VESSEL FORMATION | RECEPTOR | IMMUNOLOGY | HYPOXIA | Cell Hypoxia - immunology | Humans | Neoplasms, Experimental - enzymology | Monocytes - metabolism | Neoplasms, Experimental - pathology | Lymphocyte Subsets - metabolism | RNA, Messenger - biosynthesis | Cell Membrane - pathology | Monocytes - pathology | Angiopoietin-2 - physiology | Granulocytes - pathology | Neovascularization, Pathologic - immunology | Granulocytes - metabolism | Receptor, TIE-2 - physiology | Inflammation Mediators - physiology | Lymphocyte Subsets - pathology | Cytokines - metabolism | Macrophages - pathology | Gene Expression Regulation - immunology | RNA, Messenger - genetics | Receptor, TIE-2 - biosynthesis | Cells, Cultured | Granulocytes - enzymology | Macrophages - enzymology | Receptor, TIE-2 - genetics | Cell Membrane - enzymology | Monocytes - enzymology | Macrophages - metabolism | Animals | Up-Regulation - immunology | Lymphocyte Subsets - enzymology | Cell Membrane - immunology | Mice | Cytokines - antagonists & inhibitors | Chemotaxis, Leukocyte - immunology | Neoplasms, Experimental - blood supply
TUMOR-NECROSIS-FACTOR | HUMAN PERIPHERAL-BLOOD | ANGIOGENESIS | MACROPHAGES | INFLAMMATION | ENDOTHELIAL-CELLS | IN-VIVO | VESSEL FORMATION | RECEPTOR | IMMUNOLOGY | HYPOXIA | Cell Hypoxia - immunology | Humans | Neoplasms, Experimental - enzymology | Monocytes - metabolism | Neoplasms, Experimental - pathology | Lymphocyte Subsets - metabolism | RNA, Messenger - biosynthesis | Cell Membrane - pathology | Monocytes - pathology | Angiopoietin-2 - physiology | Granulocytes - pathology | Neovascularization, Pathologic - immunology | Granulocytes - metabolism | Receptor, TIE-2 - physiology | Inflammation Mediators - physiology | Lymphocyte Subsets - pathology | Cytokines - metabolism | Macrophages - pathology | Gene Expression Regulation - immunology | RNA, Messenger - genetics | Receptor, TIE-2 - biosynthesis | Cells, Cultured | Granulocytes - enzymology | Macrophages - enzymology | Receptor, TIE-2 - genetics | Cell Membrane - enzymology | Monocytes - enzymology | Macrophages - metabolism | Animals | Up-Regulation - immunology | Lymphocyte Subsets - enzymology | Cell Membrane - immunology | Mice | Cytokines - antagonists & inhibitors | Chemotaxis, Leukocyte - immunology | Neoplasms, Experimental - blood supply
Journal Article
Circulation Research, ISSN 0009-7330, 05/2012, Volume 110, Issue 11, pp. 1423 - 1434
RATIONALE:RhoA and Rho kinase contribute to pulmonary vasoconstriction and vascular remodeling in pulmonary hypertension. RhoB, a protein homologous to RhoA...
smooth muscle cells | endothelium | hypoxia | Rho GTPases | pulmonary hypertension | TRANSFORMATION | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | KINASE INHIBITORS | NEURAL CREST CELLS | FARNESYLTRANSFERASE INHIBITORS | RAC | EPIDERMAL-GROWTH-FACTOR | PERIPHERAL VASCULAR DISEASE | MICE | ACTIN CYTOSKELETON | HYPERTENSION | HEMATOLOGY | Cell Proliferation | Humans | Male | rhoA GTP-Binding Protein - metabolism | rhoB GTP-Binding Protein - metabolism | Actomyosin - genetics | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Farnesyltranstransferase - antagonists & inhibitors | Hypertension, Pulmonary - drug therapy | rhoB GTP-Binding Protein - genetics | Myocytes, Smooth Muscle - drug effects | Hypertension, Pulmonary - enzymology | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Hypoxia - enzymology | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Myocytes, Smooth Muscle - enzymology | Polyenes - pharmacology | Stress Fibers - enzymology | Enzyme Inhibitors - pharmacology | Familial Primary Pulmonary Hypertension | Hypoxia - complications | Actomyosin - metabolism | Pulmonary Artery - enzymology | Mice, Knockout | Polyunsaturated Alkamides - pharmacology | Mice | Myosin Light Chains - metabolism | Enzyme Activation | Chronic Disease | Endothelial Cells - enzymology | Hypertension, Pulmonary - etiology | Muscle, Smooth, Vascular - enzymology | Cell Movement | Phosphorylation | Capillary Permeability | Serine | Cell Hypoxia | Farnesyltranstransferase - metabolism | Transfection | Mice, Inbred C57BL | Cells, Cultured | Vasoconstriction | Hypertension, Pulmonary - genetics | Hypoxia - genetics | Animals | rhoB GTP-Binding Protein - deficiency | Endothelial Cells - drug effects | Medical and Health Sciences | Medicin och hälsovetenskap
smooth muscle cells | endothelium | hypoxia | Rho GTPases | pulmonary hypertension | TRANSFORMATION | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | KINASE INHIBITORS | NEURAL CREST CELLS | FARNESYLTRANSFERASE INHIBITORS | RAC | EPIDERMAL-GROWTH-FACTOR | PERIPHERAL VASCULAR DISEASE | MICE | ACTIN CYTOSKELETON | HYPERTENSION | HEMATOLOGY | Cell Proliferation | Humans | Male | rhoA GTP-Binding Protein - metabolism | rhoB GTP-Binding Protein - metabolism | Actomyosin - genetics | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Farnesyltranstransferase - antagonists & inhibitors | Hypertension, Pulmonary - drug therapy | rhoB GTP-Binding Protein - genetics | Myocytes, Smooth Muscle - drug effects | Hypertension, Pulmonary - enzymology | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Hypoxia - enzymology | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Myocytes, Smooth Muscle - enzymology | Polyenes - pharmacology | Stress Fibers - enzymology | Enzyme Inhibitors - pharmacology | Familial Primary Pulmonary Hypertension | Hypoxia - complications | Actomyosin - metabolism | Pulmonary Artery - enzymology | Mice, Knockout | Polyunsaturated Alkamides - pharmacology | Mice | Myosin Light Chains - metabolism | Enzyme Activation | Chronic Disease | Endothelial Cells - enzymology | Hypertension, Pulmonary - etiology | Muscle, Smooth, Vascular - enzymology | Cell Movement | Phosphorylation | Capillary Permeability | Serine | Cell Hypoxia | Farnesyltranstransferase - metabolism | Transfection | Mice, Inbred C57BL | Cells, Cultured | Vasoconstriction | Hypertension, Pulmonary - genetics | Hypoxia - genetics | Animals | rhoB GTP-Binding Protein - deficiency | Endothelial Cells - drug effects | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Circulation Research, ISSN 0009-7330, 05/2012, Volume 110, Issue 11, pp. 1484 - 1497
RATIONALE:Pulmonary arterial hypertension (PAH) is a lethal syndrome characterized by pulmonary vascular obstruction caused, in part, by pulmonary artery...
mitotic checkpoint | cyclin B1/cyclin-dependent kinase 1 | mitochondrial fission | hypoxia-inducible factor-1 | mitochondrial division inhibitor-1 | CARDIAC & CARDIOVASCULAR SYSTEMS | ENTRY | INDUCIBLE FACTOR 1-ALPHA | HYPOXIA | DRP1 | PATHWAY | ARTERIAL-HYPERTENSION | ENDOTHELIAL-CELLS | GENE-EXPRESSION | GERMLINE MUTATIONS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | K+ CHANNELS | Antihypertensive Agents - pharmacology | Humans | Monocrotaline | Male | Cyclin B1 - metabolism | Cobalt | Hypertension, Pulmonary - therapy | CDC2 Protein Kinase - metabolism | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Mitochondrial Proteins - metabolism | Myocytes, Smooth Muscle - drug effects | Hypertension, Pulmonary - enzymology | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Myocytes, Smooth Muscle - enzymology | Dynamins - genetics | Rats | Familial Primary Pulmonary Hypertension | Hypoxia - complications | Rats, Sprague-Dawley | Pulmonary Artery - enzymology | Cell Cycle Checkpoints | GTP Phosphohydrolases - metabolism | GTP Phosphohydrolases - genetics | Mitochondria, Muscle - drug effects | Enzyme Activation | Hypertension, Pulmonary - etiology | Muscle, Smooth, Vascular - enzymology | Dynamins - metabolism | Phosphorylation | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Serine | Myocytes, Smooth Muscle - pathology | Mitochondrial Proteins - genetics | Case-Control Studies | Transfection | Quinazolinones - pharmacology | Mitochondria, Muscle - enzymology | Mitochondria, Muscle - pathology | Cells, Cultured | Muscle, Smooth, Vascular - pathology | Animals | Mitosis - drug effects | Glycolysis | Cell Proliferation - drug effects | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Genetic Therapy - methods | Hypoxia-inducible factor 1 | CDK1-cyclin B1 | Mitochondrial division inhibitor-1 (Mdivi-1) | Mitochondrial fission | Mitotic check point
mitotic checkpoint | cyclin B1/cyclin-dependent kinase 1 | mitochondrial fission | hypoxia-inducible factor-1 | mitochondrial division inhibitor-1 | CARDIAC & CARDIOVASCULAR SYSTEMS | ENTRY | INDUCIBLE FACTOR 1-ALPHA | HYPOXIA | DRP1 | PATHWAY | ARTERIAL-HYPERTENSION | ENDOTHELIAL-CELLS | GENE-EXPRESSION | GERMLINE MUTATIONS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | K+ CHANNELS | Antihypertensive Agents - pharmacology | Humans | Monocrotaline | Male | Cyclin B1 - metabolism | Cobalt | Hypertension, Pulmonary - therapy | CDC2 Protein Kinase - metabolism | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Mitochondrial Proteins - metabolism | Myocytes, Smooth Muscle - drug effects | Hypertension, Pulmonary - enzymology | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Myocytes, Smooth Muscle - enzymology | Dynamins - genetics | Rats | Familial Primary Pulmonary Hypertension | Hypoxia - complications | Rats, Sprague-Dawley | Pulmonary Artery - enzymology | Cell Cycle Checkpoints | GTP Phosphohydrolases - metabolism | GTP Phosphohydrolases - genetics | Mitochondria, Muscle - drug effects | Enzyme Activation | Hypertension, Pulmonary - etiology | Muscle, Smooth, Vascular - enzymology | Dynamins - metabolism | Phosphorylation | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Serine | Myocytes, Smooth Muscle - pathology | Mitochondrial Proteins - genetics | Case-Control Studies | Transfection | Quinazolinones - pharmacology | Mitochondria, Muscle - enzymology | Mitochondria, Muscle - pathology | Cells, Cultured | Muscle, Smooth, Vascular - pathology | Animals | Mitosis - drug effects | Glycolysis | Cell Proliferation - drug effects | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Genetic Therapy - methods | Hypoxia-inducible factor 1 | CDK1-cyclin B1 | Mitochondrial division inhibitor-1 (Mdivi-1) | Mitochondrial fission | Mitotic check point
Journal Article
Cancer Cell, ISSN 1535-6108, 2008, Volume 13, Issue 3, pp. 181 - 183
Small numbers of proangiogenic bone marrow-derived cells (BMDCs) can play pivotal roles in tumor progression. In this issue of , two papers, utilizing...
RECRUITMENT | COLLAGEN | ANGIOGENESIS | ONCOLOGY | GROWTH | RELEASE | MMP-9 | Myeloid Cells - enzymology | Glioblastoma - enzymology | Bone Marrow Cells - enzymology | Neoplasms, Experimental - enzymology | Hypoxia-Inducible Factor 1, alpha Subunit - deficiency | Neovascularization, Pathologic - pathology | Cell Hypoxia | Neoplasms, Experimental - pathology | Neovascularization, Pathologic - enzymology | Matrix Metalloproteinase 9 - metabolism | Monocytes - transplantation | Stem Cells - enzymology | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Matrix Metalloproteinase 9 - genetics | Bone Marrow Transplantation | Neovascularization, Pathologic - prevention & control | Signal Transduction | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Neoplasm Invasiveness | Neoplasms, Experimental - therapy | Matrix Metalloproteinase 9 - deficiency | Mice, Knockout | Monocytes - enzymology | Animals | Myeloid Cells - transplantation | Mice | Angiogenic Proteins - metabolism | Endothelial Cells - enzymology | Glioblastoma - blood supply | Cell Movement | Neoplasms, Experimental - blood supply | Development and progression | Neovascularization | Analysis | Tumors
RECRUITMENT | COLLAGEN | ANGIOGENESIS | ONCOLOGY | GROWTH | RELEASE | MMP-9 | Myeloid Cells - enzymology | Glioblastoma - enzymology | Bone Marrow Cells - enzymology | Neoplasms, Experimental - enzymology | Hypoxia-Inducible Factor 1, alpha Subunit - deficiency | Neovascularization, Pathologic - pathology | Cell Hypoxia | Neoplasms, Experimental - pathology | Neovascularization, Pathologic - enzymology | Matrix Metalloproteinase 9 - metabolism | Monocytes - transplantation | Stem Cells - enzymology | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Matrix Metalloproteinase 9 - genetics | Bone Marrow Transplantation | Neovascularization, Pathologic - prevention & control | Signal Transduction | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Neoplasm Invasiveness | Neoplasms, Experimental - therapy | Matrix Metalloproteinase 9 - deficiency | Mice, Knockout | Monocytes - enzymology | Animals | Myeloid Cells - transplantation | Mice | Angiogenic Proteins - metabolism | Endothelial Cells - enzymology | Glioblastoma - blood supply | Cell Movement | Neoplasms, Experimental - blood supply | Development and progression | Neovascularization | Analysis | Tumors
Journal Article
Science, ISSN 0036-8075, 1/2009, Volume 323, Issue 5911, pp. 256 - 259
Histone deacetylase 4 (HDAC4) shuttles between the nucleus and cytoplasm and serves as a nuclear co-repressor that regulates bone and muscle development. We...
Retinal rods | Neurons | Neuroglia | Stem cells | Amacrine cells | Retinal degeneration | Photoreceptors | Retina | Reports | Physiological regulation | Cytoplasm | CONTROLS CHONDROCYTE HYPERTROPHY | MULTIDISCIPLINARY SCIENCES | MOUSE | MEF2 TRANSCRIPTION FACTOR | PHOSPHODIESTERASE | DIFFERENTIATION | RETINITIS-PIGMENTOSA | BETA-SUBUNIT | INTRACELLULAR TRAFFICKING | CELL-DEATH | DEGENERATION | Cytoplasm - enzymology | Histone Deacetylases - genetics | Cell Survival | Electroporation | Histone Deacetylases - metabolism | Rhodopsin - metabolism | Cell Nucleus - enzymology | Animals | Rhodopsin - genetics | Transfection | Retina - cytology | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Retina - enzymology | Retinal Rod Photoreceptor Cells - physiology | Retinal Rod Photoreceptor Cells - enzymology | Mice | Acetylation | Mutation | Retinal Degeneration - pathology | Retinal Neurons - enzymology | Retinal Degeneration - enzymology | Retinal Neurons - physiology | Apoptosis | Histones | Cell physiology | Research | Properties | Genetics | Neurosciences | Ophthalmology | Rodents
Retinal rods | Neurons | Neuroglia | Stem cells | Amacrine cells | Retinal degeneration | Photoreceptors | Retina | Reports | Physiological regulation | Cytoplasm | CONTROLS CHONDROCYTE HYPERTROPHY | MULTIDISCIPLINARY SCIENCES | MOUSE | MEF2 TRANSCRIPTION FACTOR | PHOSPHODIESTERASE | DIFFERENTIATION | RETINITIS-PIGMENTOSA | BETA-SUBUNIT | INTRACELLULAR TRAFFICKING | CELL-DEATH | DEGENERATION | Cytoplasm - enzymology | Histone Deacetylases - genetics | Cell Survival | Electroporation | Histone Deacetylases - metabolism | Rhodopsin - metabolism | Cell Nucleus - enzymology | Animals | Rhodopsin - genetics | Transfection | Retina - cytology | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Retina - enzymology | Retinal Rod Photoreceptor Cells - physiology | Retinal Rod Photoreceptor Cells - enzymology | Mice | Acetylation | Mutation | Retinal Degeneration - pathology | Retinal Neurons - enzymology | Retinal Degeneration - enzymology | Retinal Neurons - physiology | Apoptosis | Histones | Cell physiology | Research | Properties | Genetics | Neurosciences | Ophthalmology | Rodents
Journal Article